Leukemia

Dr. Dima El-Sharkawi discusses how hairy cell leukemia typically presents in patients and the challenges clinicians face in identifying the disease early.

The FDA has approved Revuforj for relapsed or refractory acute myeloid leukemia with an NPM1 mutation.

Dr. Alessandro Gozzetti highlights fertility and reproductive health as often overlooked but vital aspects of survivorship in hairy cell leukemia.

Combining Rituxan with Mavenclad or Zelboraf upfront can extend remissions safely and should become standard first-line therapy for hairy cell leukemia.

The author and advocate, facing leukemia for the third time in 15 years, sat down for an interview with CURE.

Leukemia is a blood cancer that disrupts normal cell production, leading to infection risk, anemia and bleeding, and requiring tailored treatments.

The changing seasons offer a profound metaphor for the circle of life, an idea that resonates deeply with me.

In observation of Leukemia Awareness Month in September, CURE spoke with an expert about basics of the disease.

Facing a cancer diagnosis was terrifying, but determination, lifestyle changes, and a strong support system helped me fight and find hope.

After an blood cancer diagnosis and stem cell transplant, I found purpose in crochet, turning fear into creativity and connection one stitch at a time.

Facing leukemia and uncertainty, I leaned on love and resolve to keep living day by day, despite fear and an unknown future ahead.

I’m in remission from small lymphocytic lymphoma and off treatment, savoring this break while learning to live with the uncertainty that still lingers.

I celebrated five years since my bone marrow transplant with a surprise video from my donor, a beautiful reminder of the life she helped me keep.

The FDA has granted priority review to an application for Revuforj for the treatment of relapsed or refractory mutant NPM1 acute myeloid leukemia.

I’ve lived with large granular lymphocytic leukemia for 16 years and have learned to spend my energy wisely, embrace palliative care and choose joy over anger.

The FDA granted a positive review for an acute myeloid leukemia drug trial, with initial dosing expected in 2025.

Managing diabetes and chronic lymphocytic leukemia is challenging, but with proactive care, mindfulness and diet changes, I'm working to balance both.

The first patients have been dosed in a trial of CAR T therapy in relapsed/refractory T cell acute lymphoblastic leukemia or T cell lymphoblastic lymphoma.

Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease across leukemia subtypes.

Nutrition is a challenge for many patients with cancer.

Cancer is one of the most expensive medical conditions to treat in the U.S.

The Food and Drug Administration granted fast track designation to AUTX-703 for relapsed or refractory acute myelogenous leukemia.

From the deaths of John Sykes and former Planned Parenthood President Cecile Richards to an update from Mike Peters, here’s this week’s cancer news.

Patients with lymphoma or leukemia with methotrexate-induced acute kidney injury experienced improved renal outcomes following glucarpidase treatment.

As a cancer treatment waiting room volunteer, I’ve discovered a unique community of shared experiences and unexpected connections.